Print

Medifocus Announces Institutional Review Board (IRB) Approval for Second USA Site for Its Phase III Pivotal Breast Cancer Treatment Study  
6/3/2011 9:09:23 AM

Medifocus Inc. (OTC:MDFZF.PK) and (TSXV:MFS) is pleased to announce that the Western Institutional Review Board (WIRB) has granted IRB approval to the Comprehensive Breast Center of Coral Springs Florida, a division of 21st Century Oncology to conduct Medifocus’ Pivotal Phase III Breast Cancer Treatment Study, under the supervision of Dr. Mary Beth Tomaselli, M.D.
//-->